Diagnostika a liečba (eradikácia) Helicobactera pylori (Hp) je medicínskym aj ekonomickým problémom. Narastajúca rezistencia baktérie na makrolidy a metronidazol, novšie aj na chinolóny (levofloxacín) a nárast nákladov na diagnostiku či novozavádzané liečivá, nás nútia hľadať racionálne prístupy k liečbe Hp a dodržiavať európske aj národné odporúčania. Práca na novom odbornom usmernení z dielne MZ SR, hlavného odborníka pre gastroenterológiu a pracovnej skupiny pre Hp pri SGS zabrala viac ako rok. Tretie upravené a doplnené odporúčania pre diagnostiku a liečbu Hp potvrdilo nutnosť medziodborovej spolupráce.

Diagnostics and treatment of Helicobacter pylori (Hp) is a medical and economical problem as well. Rising resistance of bacteria towards macrolids and metronidazol, lately also to chinolons (Levofloxacin), together with a growth of costs needed for diagnostics or newly introduced medicaments, force us to look for the rational approach to Hp treatment that have to comply with European and national guidelines. Work on new technical directions from the workshop of Healthcare Ministry of the Slovak Republic, general expert for gastroenterology, and the working group for Hp at the SGS, has taken more than one year time. These revised and filled in guidelines for Hp diagnostics and treatment proved the necessity of cooperation among medical departments and branches.

Mandatory recommendation for the treatment of helicobacter pylori infection